Hans Matter

Years Active: 2020-2023
Publications (10 Years): 5

Sanofi-Aventis Deutschland GmbH

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Sanofi-Aventis Deutschland GmbH

Germany

Senior Research Scientist :: Integrated Drug Discovery

Publications

Susanne Sauer, Hans Matter, Gerhard Hessler, Christoph Grebner
Integrating Reaction Schemes, Reagent Databases, and Virtual Libraries into Fragment-Based Design by Reinforcement Learning. Journal of chemical information and modeling (2023)
Maxime Langevin, Christoph Grebner, Stefan Güssregen, Susanne Sauer, Yi Li, Hans Matter, Marc Bianciotto
Impact of Applicability Domains to Generative Artificial Intelligence. ACS omega 8 (25) (2023)
Tobias Harren, Hans Matter, Gerhard Hessler, Matthias Rarey, Christoph Grebner
Interpretation of Structure-Activity Relationships in Real-World Drug Design Data Sets Using Explainable Artificial Intelligence. Journal of chemical information and modeling 62 (3) (2022)
María Isabel Fernández-Bachiller, Songhwan Hwang, María Elena Schembri, Peter Lindemann, Mónica Guberman, Svenja Herziger, Edgar Specker, Hans Matter, David W Will, Jörg Czech, Michael Wagner, Armin Bauer, Herman Schreuder, Kurt Ritter, Matthias Urmann, Volkmar Wehner, Han Sun, Marc Nazare
Probing Factor Xa Protein-Ligand Interactions: Accurate Free Energy Calculations and Experimental Validations of Two Series of High-Affinity Ligands. Journal of medicinal chemistry 65 (19) (2022)
Hans Matter, Christian Buning, Dan Dragos Stefanescu, Sven Ruf, Gerhard Hessler
Using Graph Databases to Investigate Trends in Structure-Activity Relationship Networks. Journal of chemical information and modeling 60 (12) (2020)

Hans Matter.css-eqlu8i{font-size:small;padding-left:4px;}